BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ko SY, Kim BK, Kwon SY, Kim KH, Kim JH, Choe WH, Lee CH. Clonal evolution of hepatitis B virus polymerase gene mutations during lamivudine-adefovir combination treatment. World J Gastroenterol 2012; 18(44): 6437-6446 [PMID: 23197889 DOI: 10.3748/wjg.v18.i44.6437]
URL: https://www.wjgnet.com/1007-9327/full/v18/i44/6437.htm
Number Citing Articles
1
YANG WANG, SHUANG LIU, YU CHEN, SUJUN ZHENG, LI ZHOU, TSEN HUA, SHAOFEI SUI, FENGMIN LU, ZHONGPING DUAN. Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyExperimental and Therapeutic Medicine 2016; 11(1): 117 doi: 10.3892/etm.2015.2855
2
Adefovir/lamivudineReactions Weekly 2021; 1853(1): 22 doi: 10.1007/s40278-021-94888-2
3
Youn Jee Yeo, Kyoungmin Roh, Joo Young Bang, Eun Hee Lee, Hyung Soon Park, Dong-Eun Kim. Quantitative detection of single base mutation by combining PNA hybridization and MALDI-TOF mass analysisChemical Communications 2013; 49(36): 3754 doi: 10.1039/c3cc00070b
4
YANG WANG, SHUANG LIU, YU CHEN, SUJUN ZHENG, LI ZHOU, FENGMIN LU, ZHONGPING DUAN. Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis BExperimental and Therapeutic Medicine 2016; 11(6): 2293 doi: 10.3892/etm.2016.3230